DLOUHA, Lucie, Terezie PELIKANOVA, Jiri VELEBA, Vera ADAMKOVA, Vera LANSKA, Tomas SOSNA, Lukáš PÁCAL, Kateřina KAŇKOVÁ and Jaroslav A. HUBACEK. The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics. MOLECULAR BIOLOGY REPORTS. DORDRECHT: Springer, 2021, vol. 48, No 8, p. 5873-5879. ISSN 0301-4851. Available from: https://dx.doi.org/10.1007/s11033-021-06581-w.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The APOE4 allele is associated with a decreased risk of retinopathy in type 2 diabetics
Authors DLOUHA, Lucie (203 Czech Republic), Terezie PELIKANOVA (203 Czech Republic), Jiri VELEBA (203 Czech Republic), Vera ADAMKOVA (203 Czech Republic), Vera LANSKA (203 Czech Republic), Tomas SOSNA (203 Czech Republic), Lukáš PÁCAL (203 Czech Republic, belonging to the institution), Kateřina KAŇKOVÁ (203 Czech Republic, belonging to the institution) and Jaroslav A. HUBACEK (203 Czech Republic, guarantor).
Edition MOLECULAR BIOLOGY REPORTS, DORDRECHT, Springer, 2021, 0301-4851.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher Netherlands
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 2.742
RIV identification code RIV/00216224:14110/21:00120128
Organization unit Faculty of Medicine
Doi http://dx.doi.org/10.1007/s11033-021-06581-w
UT WoS 000679622300004
Keywords in English Retinopathy; T2DM; Apolipoprotein E; Polymorphism; Gender
Tags 14110518, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Tereza Miškechová, učo 341652. Changed: 18/1/2022 14:43.
Abstract
Background Common polymorphisms within the apolipoprotein E (APOE) gene are suggested to be associated with the development of type 2 diabetes mellitus (T2DM), but the potential association with T2DM complications (nephropathy, neuropathy and retinopathy) remains unclear. We perform the case-control study to analyse the association between the APOE polymorphism and risk of T2DM and to analysed the potential relationship between the APOE and T2DM complications. Methods and results APOE variants (rs429358 and rs7412) were genotyped by TaqMan assay in T2DM patients (N = 1274; N = 829 with complications including retinopathy, neuropathy and nephropathy status) and with PCR-RFLP in healthy nondiabetic controls (N = 2055). The comparison of subjects with genotypes associated with low plasma cholesterol (APOE2/E2 and APOE2/E3 carriers vs. others) did not show an association with T2DM (OR [95% CI] = 0.88 [0.71-1.08). The differences remained insignificant after adjusting for diabetes duration, sex and BMI. Carriers of at least one APOE4 allele (rs429358) are protected against T2DM related retinopathy (OR [95% CI] = 0.65 [0.42-0.99]. Protection against retinopathy is driven mostly by females (OR [95% CI] = 0.50 [0.25-0.99]); and remains significant (P = 0.044) after adjustment for diabetes duration and BMI. Conclusion Common APOE polymorphism was not associated with T2DM in the Czech population. Yet, APOE4 allele revealed an association with retinopathy. In particular, female T2DM patients with at least one APOE4 allele exhibit lower prevalence of retinopathy in our study subjects.
Links
NV18-01-00046, research and development projectName: Genetické skóre v predikci rizika diabetu a jeho komplikací
Investor: Ministry of Health of the CR
PrintDisplayed: 21/7/2024 17:23